Tag: cerebroprotective drugs
AptaTargets announces publication of APRIL trial data in JAMA Neurology
As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy...
Astrocyte to initiate extended infusion Phase 1b study of cerebroprotective drug
Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers....